Omar I. Vivar, Ph.D. - Publications

Affiliations: 
2007 University of California, Berkeley, Berkeley, CA, United States 
Area:
Molecular Biology, Cell Biology, Pharmacology

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Saunier EF, Vivar OI, Rubenstein A, Zhao X, Olshansky M, Baggett S, Staub RE, Tagliaferri M, Cohen I, Speed TP, Baxter JD, Leitman DC. Estrogenic plant extracts reverse weight gain and fat accumulation without causing mammary gland or uterine proliferation. Plos One. 6: e28333. PMID 22163294 DOI: 10.1371/Journal.Pone.0028333  0.356
2010 Leitman DC, Paruthiyil S, Vivar OI, Saunier EF, Herber CB, Cohen I, Tagliaferri M, Speed TP. Regulation of specific target genes and biological responses by estrogen receptor subtype agonists. Current Opinion in Pharmacology. 10: 629-36. PMID 20951642 DOI: 10.1016/J.Coph.2010.09.009  0.511
2010 Vivar OI, Zhao X, Saunier EF, Griffin C, Mayba OS, Tagliaferri M, Cohen I, Speed TP, Leitman DC. Estrogen receptor beta binds to and regulates three distinct classes of target genes. The Journal of Biological Chemistry. 285: 22059-66. PMID 20404318 DOI: 10.1074/Jbc.M110.114116  0.454
2010 Vivar OI, Saunier EF, Leitman DC, Firestone GL, Bjeldanes LF. Selective activation of estrogen receptor-beta target genes by 3,3'-diindolylmethane. Endocrinology. 151: 1662-7. PMID 20160136 DOI: 10.1210/En.2009-1028  0.415
2010 Levy N, Paruthiyil S, Zhao X, Vivar OI, Saunier EF, Griffin C, Tagliaferri M, Cohen I, Speed TP, Leitman DC. Unliganded estrogen receptor-beta regulation of genes is inhibited by tamoxifen. Molecular and Cellular Endocrinology. 315: 201-7. PMID 19744542 DOI: 10.1016/j.mce.2009.08.030  0.404
2009 Vivar OI, Lin CL, Firestone GL, Bjeldanes LF. 3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status. Biochemical Pharmacology. 78: 469-76. PMID 19433067 DOI: 10.1016/J.Bcp.2009.05.008  0.365
Show low-probability matches.